Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

نتائج البحث

Display Settings
النتائج لكل صفحة: 10
Sort By: Relevance
Filter
  • 1-10 ل  17 نتائج ل ""Chloride Channel Agonists""

فلترة النتائج

Subject : lubiprostone
إعادة تعيين خيارات الفبترة
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Short Chain Fatty Acids Effect on Chloride Channel ClC-2 as a Possible Mechanism for Lubiprostone Intestinal Action.

  • Authors : Catalán MA; Centro de Estudios Científicos (CECs), Avenida Arturo Prat 514, Valdivia 5110466, Chile.; Instituto de Fisiología, Facultad de Medicina, Universidad Austral de Chile, Valdivia 5090000, Chile.

Subjects: Chloride Channel Agonists/Chloride Channel Agonists/Chloride Channel Agonists/*therapeutic use ; Chloride Channels/Chloride Channels/Chloride Channels/*drug effects ; Fatty Acids, Volatile/Fatty Acids, Volatile/Fatty Acids, Volatile/*metabolism

  • Source: Cells [Cells] 2020 Jul 26; Vol. 9 (8). Date of Electronic Publication: 2020 Jul 26.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101600052 Publication Model: Electronic Cited Medium: Internet ISSN: 2073-4409

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Report

Response to lubiprostone in chronic constipation is associated with increased mucus and mucin output: a randomized clinical trial.

  • Authors : Tarasiuk A; Department of Biochemistry, Medical University of Lodz, Lodz, Poland.; Milad M

Subjects: Chloride Channel Agonists/Chloride Channel Agonists/Chloride Channel Agonists/*administration & dosage ; Constipation/Constipation/Constipation/*drug therapy ; Defecation/Defecation/Defecation/*drug effects

  • Source: Journal of gastrointestinal and liver diseases : JGLD [J Gastrointestin Liver Dis] 2019 Sep 01; Vol. 28 (3), pp. 263-264. Date of Electronic Publication: 2019 Sep 01.Publisher:

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Lubiprostone improves intestinal permeability in humans, a novel therapy for the leaky gut: A prospective randomized pilot study in healthy volunteers.

  • Authors : Kato T; Department of Gastroenterology and Hepatology, Yokohama City University School of Medicine, Yokohama, Kanagawa, Japan.; Honda Y

Subjects: Chloride Channel Agonists/Chloride Channel Agonists/Chloride Channel Agonists/*therapeutic use ; Irritable Bowel Syndrome/Irritable Bowel Syndrome/Irritable Bowel Syndrome/*drug therapy ; Lubiprostone/Lubiprostone/Lubiprostone/*therapeutic use

  • Source: PloS one [PLoS One] 2017 Apr 14; Vol. 12 (4), pp. e0175626. Date of Electronic Publication: 2017 Apr 14 (Print Publication: 2017).Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Negative chronotropic and inotropic effects of lubiprostone on iPS cell-derived cardiomyocytes via activation of CFTR.

  • Authors : Akita H; Department of Cardiovascular Medicine, Fukushima Medical University, Fukushima, Japan.; Yoshie S

Subjects: Chloride Channel Agonists/Chloride Channel Agonists/Chloride Channel Agonists/*pharmacology ; Cystic Fibrosis Transmembrane Conductance Regulator/Cystic Fibrosis Transmembrane Conductance Regulator/Cystic Fibrosis Transmembrane Conductance Regulator/*metabolism ; Lubiprostone/Lubiprostone/Lubiprostone/*pharmacology

  • Source: BMC complementary medicine and therapies [BMC Complement Med Ther] 2020 Apr 19; Vol. 20 (1), pp. 118. Date of Electronic Publication: 2020 Apr 19.Publisher: BioMed Central Country of Publication: England NLM ID: 101761232 Publication Model: Electronic Cited Medium: Internet ISSN: 2662-7671

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Lubiprostone as a potential therapeutic agent to improve intestinal permeability and prevent the development of atherosclerosis in apolipoprotein E-deficient mice.

  • Authors : Arakawa K; Department of Medical Science and Cardiorenal Medicine, Yokohama City University, School of Medicine, Kanagawa, Japan.; Ishigami T

Subjects: Apolipoproteins E/Apolipoproteins E/Apolipoproteins E/*deficiency ; Atherosclerosis/Atherosclerosis/Atherosclerosis/*prevention & control ; Ileum/Ileum/Ileum/*drug effects

  • Source: PloS one [PLoS One] 2019 Jun 17; Vol. 14 (6), pp. e0218096. Date of Electronic Publication: 2019 Jun 17 (Print Publication: 2019).Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Chronic stress and intestinal permeability: Lubiprostone regulates glucocorticoid receptor-mediated changes in colon epithelial tight junction proteins, barrier function, and visceral pain in the rodent and human.

  • Authors : Zong Y; Department of Gastroenterology, Beijing Friendship Hospital, Capital Medical University, Beijing, China.; Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan.

Subjects: Stress, Psychological*/Stress, Psychological*/Stress, Psychological*/complications ; Stress, Psychological*/Stress, Psychological*/Stress, Psychological*/metabolism ; Stress, Psychological*/Stress, Psychological*/Stress, Psychological*/physiopathology

  • Source: Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society [Neurogastroenterol Motil] 2019 Feb; Vol. 31 (2), pp. e13477. Date of Publisher: Blackwell Scientific Publications Country of Publication: England NLM ID: 9432572 Publication Model: Print-Electronic Cited Medium: Internet

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Lubiprostone for Opioid-Induced Constipation Does Not Interfere with Opioid Analgesia in Patients with Chronic Noncancer Pain.

  • Authors : Spierings EL; Headache & Face Pain Program, Tufts Medical Center, and Craniofacial Pain Center, Tufts University School of Dental Medicine, Boston, Massachusetts, U.S.A.; Brewer RP

Subjects: Analgesics, Opioid/Analgesics, Opioid/Analgesics, Opioid/*adverse effects ; Chronic Pain/Chronic Pain/Chronic Pain/*drug therapy ; Constipation/Constipation/Constipation/*chemically induced

  • Source: Pain practice : the official journal of World Institute of Pain [Pain Pract] 2017 Mar; Vol. 17 (3), pp. 312-319. Date of Electronic Publication: 2016 Mar 15.Publisher: Blackwell Science, Inc Country of Publication: United States NLM ID: 101130835 Publication Model: Print-Electronic Cited Medium: Internet

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Pharmacotherapy patterns in patients with chronic idiopathic constipation beginning treatment with linaclotide or lubiprostone in the United States

Subjects: chloride channel agonists; constipation; guanylate cyclase-c agonists

  • Source: Drugs in Context, Vol 9, Pp 1-7 (2020)

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×

Efficacy and safety of lubiprostone for the treatment of functional constipation in Chinese adult patients: A multicenter, randomized, double-blind, placebo-controlled trial

Subjects: Adult; medicine.medical_specialty; China

  • Source: Journal of digestive diseasesREFERENCES. 22(11)

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×

Lubiprostone as a potential therapeutic agent to improve intestinal permeability and prevent the development of atherosclerosis in apolipoprotein E-deficient mice

Subjects: 0301 basic medicine; Apolipoprotein E; Apolipoprotein B

  • Source: PLoS ONE, Vol 14, Iss 6, p e0218096 (2019)PLoS ONE

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
  • 1-10 ل  17 نتائج ل ""Chloride Channel Agonists""